A Clinical Study on the Use of Yiqi Yangxue Decoction Combined with Chemotherapy to Promote Rapid Postoperative Recovery in Patients with Non-Small Cell Lung Cancer

Table 1

Comparison of clinical features between the two groups.

Information	Chemotherapy group (n = 40)	TCM (n = 40)	t/χ^2
Age (years old)	53.90 ± 6.80	54.40 ± 5.16	0.370	0.712
Body mass index (kg/m^2)	22.96 ± 2.12	22.86 ± 2.26	0.204	0.839
Male (n, %)	26 (65.00)	24 (60.00)	0.213	0.644
History of smoking (n, %)	17 (42.50)	19 (47.50)	0.202	0.653
Tumour stages (n, %)			0.487	0.485
III	24 (60.00)	27 (67.50)
IV	16 (40.00)	13 (32.50)
Pathology type (n, %)			0.202	0.653
Adenocarcinoma	23 (57.50)	21 (52.50)
Squamous carcinoma	17 (42.50)	19 (47.50)
Surgical procedure (n, %)			0.237	0.888
Lung lobectomy	25 (62.50)	23 (57.50)
Pneumonectomy	12 (30.00)	14 (35.00)
Pulmonary segment resection	3 (7.50)	3 (7.50)